The goal of the Developmental Core (Core B) is to further the research priorities of the CFAR by soliciting and funding developmental projects, providing strong mentorship to junior faculty and those new to the HIV/AIDS research field, strengthening the capacity for HIV/AIDS research in developing countries, and sponsoring training and educational programs to enhance the involvement of young scientists both domestically and internationally. The Developmental Core has a strong track record of providing value added to HIV/AIDS research conducted at Brown and Tufts. Since the inception of the CFAR in 1998, the Developmental Core has supported the research base by providing $2,453,000 in developmental grants to 63 investigators (30 women, 6 minority), of whom 28 have received subsequent grants worth more than $32 million with 49 of the 65 awardees having published over 165 peer reviewed papers on their developmental research findings. The Developmental Core will continue to help meet these critical needs for HIV researchers at Brown, Tufts and our international academic-affiliated institutions in two principal ways: 1) by providing pilot funding to qualified researchers both domestically and internationally, and 2) by providing timely and effective mentoring and support to a broad spectrum of researchers, from undergraduates to junior faculty. In the first year of the CFAR, we will combine $240,000 of CFAR funds to support initial, pilot and collaborative awards to junior investigators and those new to HIV/AIDS research with $100,000 of institutional funds to support development of our international collaborators to the funding of 3 international developmental awards. The Developmental Core will be led by Drs John Coffin and Ira Wilson, with administrative support from the Program Coordinator (R. DiCesare).

Public Health Relevance

Students, trainees at all levels, and junior faculty perennially need resources to conduct pilot projects and mentoring to guide their development. The need to reduce the federal deficit makes it likely the funding for the NIH, AHRQ, CDC, and NSF will at best be flat for the next few years, which only increases pressure on junior faculty members to submit very well written, innovative grant applications that include high quality pilot data. The CFAR Developmental Core provides a mechanism for junior faculty to conduct pilot projects that will hopefully lead to successful independent funding.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
3P30AI042853-19S1
Application #
9439158
Study Section
Special Emphasis Panel (ZAI1)
Program Officer
Namkung, Ann S
Project Start
Project End
Budget Start
2016-07-01
Budget End
2018-06-30
Support Year
19
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Miriam Hospital
Department
Type
DUNS #
063902704
City
Providence
State
RI
Country
United States
Zip Code
02906
Ma, Y; Horsburgh, C R; White, L F et al. (2018) Quantifying TB transmission: a systematic review of reproduction number and serial interval estimates for tuberculosis. Epidemiol Infect 146:1478-1494
Skeer, Margie R; Ladin, Keren; Wilkins, Lindsay E et al. (2018) 'Hep C's like the common cold': understanding barriers along the HCV care continuum among young people who inject drugs. Drug Alcohol Depend 190:246-254
Dompreh, Albert; Tang, Xiaoli; Zhou, Jianlin et al. (2018) Effect of Genetic Variation of NAT2 on Isoniazid and SLCO1B1 and CES2 on Rifampin Pharmacokinetics in Ghanaian Children with Tuberculosis. Antimicrob Agents Chemother 62:
Wurcel, Alysse G; Burke, Deirdre; Skeer, Margie et al. (2018) Sex work, injection drug use, and abscesses: Associations in women, but not men. Drug Alcohol Depend 185:293-297
Adams, Joƫlla W; Bryant, Kendall J; Edelman, Jennifer E et al. (2018) Association of Cannabis, Stimulant, and Alcohol use with Mortality Prognosis Among HIV-Infected Men. AIDS Behav 22:1341-1351
Schackman, Bruce R; Gutkind, Sarah; Morgan, Jake R et al. (2018) Cost-effectiveness of hepatitis C screening and treatment linkage intervention in US methadone maintenance treatment programs. Drug Alcohol Depend 185:411-420
Bazazi, Alexander R; Vijay, Aishwarya; Crawford, Forrest W et al. (2018) HIV Testing and awareness of HIV status among people who inject drugs in greater Kuala Lumpur, Malaysia. AIDS Care 30:59-64
Krieger, Maxwell S; Yedinak, Jesse L; Buxton, Jane A et al. (2018) High willingness to use rapid fentanyl test strips among young adults who use drugs. Harm Reduct J 15:7
van den Berg, Jacob J; Javanbakht, Marjan; Gorbach, Pamina M et al. (2018) Partner Notification for Youth Living With HIV in 14 Cities in the United States. J Acquir Immune Defic Syndr 77:46-52
Hu, Liangyuan; Hogan, Joseph W; Mwangi, Ann W et al. (2018) Modeling the causal effect of treatment initiation time on survival: Application to HIV/TB co-infection. Biometrics 74:703-713

Showing the most recent 10 out of 806 publications